Dr Reddy’s Lab launches Montelukast Sodium Oral Granules

27 Sep 2012 Evaluate

Dr Reddy’s Laboratories has launched Montelukast Sodium Oral Granules, a bioequivalent generic version of Singulair (Montelukast Sodium) oral granules in the US market, following the approval by the United States Food & Drug Administration (USFDA) of its Abbreviated New Drug Application (ANDA) for Montelukast Sodium Oral Granules.

The Singulair Oral Granules brand had US sales of about $61 million for the most recent twelve months ending July 2012 according to IMS Health. The company’s Montelukast Sodium Oral Granules in 4mg are available in unit dosage package of 30.

Recently, the company launched Amoxicillin tablets Capsules and Oral Suspension, a bioequivalent generic version of Amoxil tablets, capsules and Oral Suspension in the US markets on September 17, 2012.

Dr. Reddys Lab Share Price

1267.15 -7.90 (-0.62%)
08-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.30
Dr. Reddys Lab 1267.15
Cipla 1497.45
Zydus Lifesciences 924.35
Lupin 2071.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×